TipRanks
Intuitive Surgical (IT:1ISRG)
:1ISRG
Italy Market
1ISRG
Intuitive Surgical
RESEARCH TOOLSreports

Intuitive Surgical (1ISRG) Stock Forecast & Price Target

15 Followers
See the Price Targets and Ratings of:

1ISRG Analyst Ratings

Strong Buy
22Ratings
Strong Buy
20 Buy
2 Hold
0 Sell
Based on 22 analysts giving stock ratings to
Intuitive
Surgical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1ISRG Stock 12 Month Forecast

Average Price Target

€442.14
▲(39.87% Upside)
Based on 22 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is €442.14 with a high forecast of €613.28 and a low forecast of €350.06. The average price target represents a 39.87% change from the last price of €316.10.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"303":"€303","614":"€614","380.75":"€380.8","458.5":"€458.5","536.25":"€536.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":613.2816234000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€613.28</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":442.13764674315786,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€442.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":350.06294124,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€350.06</span>\n  </div></div>","useHTML":true}}],"tickPositions":[303,380.75,458.5,536.25,614],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,358.6,378.1908941076923,397.78178821538467,417.37268232307696,436.96357643076925,456.5544705384616,476.1453646461539,495.7362587538462,515.3271528615385,534.9180469692308,554.5089410769231,574.0998351846155,593.6907292923078,{"y":613.2816234000001,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,358.6,365.02597282639675,371.45194565279354,377.87791847919027,384.30389130558706,390.7298641319838,397.1558369583806,403.5818097847773,410.0077826111741,416.4337554375708,422.8597282639676,429.28570109036434,435.71167391676113,{"y":442.13764674315786,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,358.6,357.9433031723077,357.2866063446154,356.6299095169231,355.97321268923076,355.31651586153845,354.65981903384613,354.0031222061539,353.34642537846156,352.68972855076925,352.03303172307693,351.3763348953846,350.7196380676923,{"y":350.06294124,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":370.35,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":462.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":490.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":486.65,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":422.7,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":401.2,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":387.25,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":361.65,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.95,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":304.45,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":317.85,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":358.6,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€613.28Average Price Target€442.14Lowest Price Target€350.06
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on IT:1ISRG
Anthony Petrone
Mizuho Securities
Mizuho Securities
€358.12→€371.55
Hold
17.54%
Upside
Assigned
10/13/26
Intuitive Surgical price target raised to $415 from $400 at MizuhoIntuitive Surgical price target raised to $415 from $400 at Mizuho
UBS Analyst forecast on IT:1ISRG
Patrick Wood
UBS
UBS
€447.65
Buy
41.62%
Upside
Reiterated
10/13/26
Intuitive Surgical: Buy Rating Reiterated on Long-Term Robotic Growth Runway; Price Target Maintained at $500
Leerink Partners Analyst forecast on IT:1ISRG
Mike Kratky
Leerink Partners
Leerink Partners
€406.47→€423.48
Buy
33.97%
Upside
Assigned
10/12/26
Leerink Partners Keeps Their Buy Rating on Intuitive Surgical (ISRG)
BTIG Analyst forecast on IT:1ISRG
Ryan Zimmerman
BTIG
BTIG
€419.9→€406.47
Buy
28.59%
Upside
Reiterated
10/12/26
Intuitive Surgical price target lowered to $454 from $469 at BTIGIntuitive Surgical price target lowered to $454 from $469 at BTIG
Piper Sandler Analyst forecast on IT:1ISRG
Adam Maeder
Piper Sandler
Piper Sandler
€420.79
Buy
33.12%
Upside
Reiterated
10/07/26
Intuitive Surgical (ISRG) Gets a Buy from Piper Sandler
Barclays Analyst forecast on IT:1ISRG
Christopher Pasquale
Barclays
Barclays
€434.22
Buy
37.37%
Upside
Initiated
10/07/26
Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
Citi Analyst forecast on IT:1ISRG
Joanne Wuensch
Citi
Citi
€447.65
Buy
41.62%
Upside
Reiterated
10/05/26
Intuitive Surgical (ISRG) Gets a Buy from Citi
RBC Capital Analyst forecast on IT:1ISRG
Kendall Au
RBC Capital
RBC Capital
€514.8
Buy
62.86%
Upside
Reiterated
10/01/26
RBC Capital Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
Bank of America Securities Analyst forecast on IT:1ISRG
Travis Steed
Bank of America Securities
Bank of America Securities
€420.79
Buy
33.12%
Upside
Reiterated
09/21/26
Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Intuitive Surgical (ISRG)
BMO Capital Analyst forecast on IT:1ISRG
Vik Chopra
BMO Capital
BMO Capital
―
Buy
―
Reiterated
08/28/26
Analysts Offer Insights on Healthcare Companies: Impedimed Limited (Other OTC: IPDQF) and Intuitive Surgical (NASDAQ: ISRG)
Oppenheimer Analyst forecast on IT:1ISRG
Suraj Kalia
Oppenheimer
Oppenheimer
€447.65
Buy
41.62%
Upside
Upgraded
08/12/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), Legend Biotech (NASDAQ: LEGN) and Mineralys Therapeutics, Inc. (NASDAQ: MLYS)
Bernstein Analyst forecast on IT:1ISRG
Lee Hambright
Bernstein
Bernstein
€613.28
Buy
94.02%
Upside
Reiterated
08/11/26
Intuitive Surgical: Buy Rating Reiterated as New GI Platform Progress Supports Growth; $685 Price Target Maintained
TD Cowen Analyst forecast on IT:1ISRG
Mathew Blackman
TD Cowen
TD Cowen
€434.22
Buy
37.37%
Upside
Reiterated
08/03/26
Analyst Reiterates Buy on Intuitive Surgical, Seeing Johnson & Johnson’s Ottava as a Growth Catalyst Rather Than a Competitive Threat
HSBC Analyst forecast on IT:1ISRG
Helen Fang
HSBC
HSBC
€350.06
Hold
10.74%
Upside
Downgraded
07/30/26
Intuitive Surgical downgraded to Hold from Buy at HSBCIntuitive Surgical downgraded to Hold from Buy at HSBC
Wells Fargo Analyst forecast on IT:1ISRG
Larry Biegelsen
Wells Fargo
Wells Fargo
€436.01
Buy
37.93%
Upside
Reiterated
07/23/26
Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on IT:1ISRG
Anthony Petrone
Mizuho Securities
Mizuho Securities
€358.12→€371.55
Hold
17.54%
Upside
Assigned
10/13/26
Intuitive Surgical price target raised to $415 from $400 at MizuhoIntuitive Surgical price target raised to $415 from $400 at Mizuho
UBS Analyst forecast on IT:1ISRG
Patrick Wood
UBS
UBS
€447.65
Buy
41.62%
Upside
Reiterated
10/13/26
Intuitive Surgical: Buy Rating Reiterated on Long-Term Robotic Growth Runway; Price Target Maintained at $500
Leerink Partners Analyst forecast on IT:1ISRG
Mike Kratky
Leerink Partners
Leerink Partners
€406.47→€423.48
Buy
33.97%
Upside
Assigned
10/12/26
Leerink Partners Keeps Their Buy Rating on Intuitive Surgical (ISRG)
BTIG Analyst forecast on IT:1ISRG
Ryan Zimmerman
BTIG
BTIG
€419.9→€406.47
Buy
28.59%
Upside
Reiterated
10/12/26
Intuitive Surgical price target lowered to $454 from $469 at BTIGIntuitive Surgical price target lowered to $454 from $469 at BTIG
Piper Sandler Analyst forecast on IT:1ISRG
Adam Maeder
Piper Sandler
Piper Sandler
€420.79
Buy
33.12%
Upside
Reiterated
10/07/26
Intuitive Surgical (ISRG) Gets a Buy from Piper Sandler
Barclays Analyst forecast on IT:1ISRG
Christopher Pasquale
Barclays
Barclays
€434.22
Buy
37.37%
Upside
Initiated
10/07/26
Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
Citi Analyst forecast on IT:1ISRG
Joanne Wuensch
Citi
Citi
€447.65
Buy
41.62%
Upside
Reiterated
10/05/26
Intuitive Surgical (ISRG) Gets a Buy from Citi
RBC Capital Analyst forecast on IT:1ISRG
Kendall Au
RBC Capital
RBC Capital
€514.8
Buy
62.86%
Upside
Reiterated
10/01/26
RBC Capital Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
Bank of America Securities Analyst forecast on IT:1ISRG
Travis Steed
Bank of America Securities
Bank of America Securities
€420.79
Buy
33.12%
Upside
Reiterated
09/21/26
Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Intuitive Surgical (ISRG)
BMO Capital Analyst forecast on IT:1ISRG
Vik Chopra
BMO Capital
BMO Capital
―
Buy
―
Reiterated
08/28/26
Analysts Offer Insights on Healthcare Companies: Impedimed Limited (Other OTC: IPDQF) and Intuitive Surgical (NASDAQ: ISRG)
Oppenheimer Analyst forecast on IT:1ISRG
Suraj Kalia
Oppenheimer
Oppenheimer
€447.65
Buy
41.62%
Upside
Upgraded
08/12/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), Legend Biotech (NASDAQ: LEGN) and Mineralys Therapeutics, Inc. (NASDAQ: MLYS)
Bernstein Analyst forecast on IT:1ISRG
Lee Hambright
Bernstein
Bernstein
€613.28
Buy
94.02%
Upside
Reiterated
08/11/26
Intuitive Surgical: Buy Rating Reiterated as New GI Platform Progress Supports Growth; $685 Price Target Maintained
TD Cowen Analyst forecast on IT:1ISRG
Mathew Blackman
TD Cowen
TD Cowen
€434.22
Buy
37.37%
Upside
Reiterated
08/03/26
Analyst Reiterates Buy on Intuitive Surgical, Seeing Johnson & Johnson’s Ottava as a Growth Catalyst Rather Than a Competitive Threat
HSBC Analyst forecast on IT:1ISRG
Helen Fang
HSBC
HSBC
€350.06
Hold
10.74%
Upside
Downgraded
07/30/26
Intuitive Surgical downgraded to Hold from Buy at HSBCIntuitive Surgical downgraded to Hold from Buy at HSBC
Wells Fargo Analyst forecast on IT:1ISRG
Larry Biegelsen
Wells Fargo
Wells Fargo
€436.01
Buy
37.93%
Upside
Reiterated
07/23/26
Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
ASNDAscendis Pharma
AORTArtivion
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

3 Months
Mike KratkyLeerink Partners
Success Rate
12/15 ratings generated profit
80%
Average Return
+13.07%
Copying Mike Kratky's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +13.07% per trade.
1 Year
Joanne WuenschCiti
Success Rate
23/28 ratings generated profit
82%
Average Return
+20.71%
Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 82.14% of your transactions generating a profit, with an average return of +20.71% per trade.
2 Years
Joanne WuenschCiti
Success Rate
25/28 ratings generated profit
89%
Average Return
+38.51%
Copying Joanne Wuensch's trades and holding each position for 2 Years would result in 89.29% of your transactions generating a profit, with an average return of +38.51% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1ISRG Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
2
4
3
3
1
Buy
26
36
38
37
17
Hold
5
4
3
3
1
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
34
45
45
43
19
In the current month, 1ISRG has received 18 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 1ISRG average Analyst price target in the past 3 months is 442.14.
Each month's total comprises the sum of three months' worth of ratings.

1ISRG Financial Forecast

1ISRG Earnings Forecast

Next quarter’s earnings estimate for 1ISRG is €2.37 with a range of €2.27 to €2.47. The previous quarter’s EPS was €2.51. 1ISRG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1ISRG has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1ISRG is €2.37 with a range of €2.27 to €2.47. The previous quarter’s EPS was €2.51. 1ISRG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1ISRG has Performed in-line its overall industry.

1ISRG Sales Forecast

Next quarter’s sales forecast for 1ISRG is €2.60B with a range of €2.55B to €2.68B. The previous quarter’s sales results were €2.59B. 1ISRG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1ISRG has Performed in-line its overall industry.
Next quarter’s sales forecast for 1ISRG is €2.60B with a range of €2.55B to €2.68B. The previous quarter’s sales results were €2.59B. 1ISRG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1ISRG has Performed in-line its overall industry.

1ISRG Stock Forecast FAQ

What is IT:1ISRG’s average 12-month price target, according to analysts?
Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 442.14.
    What is IT:1ISRG’s upside potential, based on the analysts’ average price target?
    Intuitive Surgical has 39.87% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Intuitive Surgical a Buy, Sell or Hold?
          Intuitive Surgical has a consensus rating of Strong Buy, which is based on 20 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Intuitive Surgical’s share price target?
            The average share price target for Intuitive Surgical is 442.14. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €613.28 ,and the lowest forecast is €350.06. The average share price target represents 39.87% Increase from the current price of €316.1.
              What do analysts say about Intuitive Surgical?
              Intuitive Surgical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 22 Wall Streets Analysts.
                How can I buy shares of Intuitive Surgical?
                To buy shares of IT:1ISRG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.